SCHEMBL7974271

SCHEMBL7974271

CCc1nc(O)c2c(ncn2Cc2ccc(C)cc2C)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNF P01375 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.38
LMNA P02545 1/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38
HTT P42858 1/20 0.38
TLR7 Q9NYK1 6/20 0.35
TP53 P04637 1/20 0.33
TSHR P16473 1/20 0.33
AURKA O14965 1/20 0.32
ROCK2 O75116 1/20 0.32
PRKCG P05129 1/20 0.32
CDK1 P06493 1/20 0.32
PRKACA P17612 1/20 0.32
RPS6KB1 P23443 1/20 0.32
CDK2 P24941 1/20 0.32
MAPK1 P28482 1/20 0.32
FLT3 P36888 1/20 0.32
GSK3A P49840 1/20 0.32
GSK3B P49841 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988883 0.85 CYP11B1 (0.46) TNFSMN1; SMN2LMNAMAPTTP53
SCHEMBL7987434 0.83 CYP11B1 (0.42) SMN1; SMN2LMNAMAPTHTTTLR7
SCHEMBL7984378 0.81 CYP11B1 (0.42) SMN1; SMN2TLR7ALDH1A1GAA
SCHEMBL7974260 0.81 CYP11B1 (0.47) SMN1; SMN2LMNAPOLBMAPTHTT
SCHEMBL7987960 0.79 CYP11B1 (0.32) LMNAPOLBHTTTLR7
SCHEMBL7984440 0.77 PDE4A (0.40) LMNAPOLBTP53MAPK1PDE4B
SCHEMBL7988129 0.76 MET (0.44) SMN1; SMN2LMNAPOLBTLR7TSHR
SCHEMBL7975252 0.76 HPGD (0.45) TNFSMN1; SMN2POLBTSHRALDH1A1
SCHEMBL7974269 0.74 TNF (0.44) TNFSMN1; SMN2LMNAPOLBMAPT
SCHEMBL7984526 0.74 MET (0.46) SMN1; SMN2HTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed